Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8595939 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 11 Pages |
Abstract
Nonagenarians treated with thrombolytics showed lower stroke-related disability at 90 days than those not treated, without significant difference in sICH and in-hospital mortality rates. These observations cannot exclude a residual confounding effect, but provide evidence that thrombolytics should not be withheld from nonagenarians because of age alone.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Réza DO, Jaime MD, RocÃo MD, Joshua Z. MD, MS, Mickael MD, Solène MD, PhD, Charlotte MD, PhD, Catharina J.M. MD, PhD, Karin MANP, Maaike MD, PhD, Brian MD, Muhib MD, Mahmoud R. MD, Daniel A. MD, Christine MD, Lizz BA, Benjamin D. MD, Craig J. MD,